InvestorsObserver
×
News Home

Is it Time to Dump Cyclerion Therapeutics Inc (CYCN) Stock After it Has Risen 17.04% in a Week?

Wednesday, January 13, 2021 01:07 PM | InvestorsObserver Analysts

Mentioned in this article

Is it Time to Dump Cyclerion Therapeutics Inc (CYCN) Stock After it Has Risen 17.04% in a Week?

Cyclerion Therapeutics Inc (CYCN) stock has gained 17.04% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bullish
Cyclerion Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CYCN!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With CYCN Stock Today?

Cyclerion Therapeutics Inc (CYCN) stock is trading at $3.64 as of 1:04 PM on Wednesday, Jan 13, a rise of $0.29, or 8.51% from the previous closing price of $3.35. The stock has traded between $3.34 and $3.75 so far today. Volume today is more active than usual. So far 596,256 shares have traded compared to average volume of 225,583 shares.

To see InvestorsObserver's Sentiment Score for Cyclerion Therapeutics Inc click here.

More About Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Click Here to get the full Stock Score Report on Cyclerion Therapeutics Inc (CYCN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App